Randomized evaluation trial on automation-assisted screening for cervical cancer: Results after 777,000 invitations

Pekka Nieminen, Laura Kotaniemi-Talonen, Matti Hakama, Jussi Tarkkanen, Jorma Martikainen, Terttu Toivonen, Jorma Ikkala, Ahti Anttila

Research output: Contribution to journalArticleScientificpeer-review

14 Citations (Scopus)

Abstract

OBJECTIVES: New cervical screening methods have been developed. They seem to become accepted in routine use without randomized trials, within existing screening programmes. Our aim was to evaluate, in a randomized setting, the performance of automation-assisted cytological screening in routine use compared with conventional Papanicoalou (Pap) screening.

SETTING: This prospective study was based on a 1:2 individually randomized design. Altogether 777,144 women were invited to attend the routine screening programme.

RESULTS: Automation-assisted screening found more Pap class III (LSIL+) findings compared with conventional study arm, relative risk (RR) 1.08 (confidence interval 1.01-1.15). Also, detection rates of verified pre-cancers were more common in automation-assisted arm, RR 1.11 (1.02-1.21).

CONCLUSIONS: Automation-assisted screening performed well compared with conventional screening. The difference was smaller than reported in non-randomized studies. A new technique may assume several years to reach the ultimate quality and can add costs without improving efficacy. Follow-up of prevented cervical cancers is required.

Original languageEnglish
Pages (from-to)23-28
Number of pages6
JournalJOURNAL OF MEDICAL SCREENING
Volume14
Issue number1
DOIs
Publication statusPublished - 2007
Publication typeA1 Journal article-refereed

Keywords

  • Adult
  • Aged
  • Automation
  • Cervical Intraepithelial Neoplasia/diagnosis
  • Female
  • Humans
  • Mass Screening/methods
  • Middle Aged
  • Uterine Cervical Neoplasms/diagnosis
  • Vaginal Smears

Fingerprint

Dive into the research topics of 'Randomized evaluation trial on automation-assisted screening for cervical cancer: Results after 777,000 invitations'. Together they form a unique fingerprint.

Cite this